Medication Treatments

MAT Pharmacy Program Expands to Arizona
Cordant Health Solutions has added a pharmacy in Mesa, Arizona, that will collaborate with clinicians in OBOT settings to deliver medicines to patients during their office visits.
Clinicians Prescribing Buprenorphine Far Below Limits of Waivers
Half of clinicians who are waivered to prescribe buprenorphine for the treatment of opioid use disorder have actually done so, and a majority are prescribing the medication for a number of patients that is well below the limit for which they are waivered, according to a new study.
Pregnant Women Shown to Face Additional Barriers to OUD Treatment in Study
A study using trained actors attempting to get addiction treatment in 10 states found that pregnant women were about 20% less likely to be accepted for treatment vs. women who are not pregnant, with the largest discrepancy involving buprenorphine prescribers.
FDA Makes Series of Recommendations on Naloxone
In a recently published communication, FDA recommended that providers discuss the availability of naloxone with patients and consider prescribing it to those deemed at increased risk of overdose.
Study: 60% of Residential Programs Offer No MOUDs
A recently published study of 2017 data found that 60% of residential treatment centers in the U.S. offered zero medications for opioid use disorder and just 15% of patients had an MOUD as part of their treatment plan.
FDA Seeks Public Input on Patient-Focused Drug Development for Stimulant Use Disorder
The FDA will conduct a virtual public meeting on patient-focused drug development for stimulant use disorder on Oct. 6, and is seeking input from individuals and families impacted by stimulant use.
Temple Researchers Receive NIDA Grant to Study Cocaine Addiction Treatment
Researchers at Temple University have received a $1.77 million grant from the National Institute on Drug Abuse to study the effects of a therapy for the treatment of cocaine use disorder, according to a media report.
1 in 5 Emergency Dept. Physicians Ready to Offer Buprenorphine
A Yale study of 400 clinicians found that just 21% of emergency department clinicians say they are prepared to prescribe buprenorphine for the treatment of opioid use disorder.
Elevate Spotlight: Best Practices in Opioid Addiction Treatment
With the far reach of the opioid epidemic and the high comorbidity of opioid addiction with other psychiatric disorders, the session will be relevant to all attendees, not just those in addiction medicine.
NCAD West: Prescription Opioid Misuse Drops, but Providers Need to Stay Vocal
During the opening plenary of NCAD West on Thursday, Colorado Consortium for Prescription Drug Abuse director Rober Valuck, PhD, RPh, FNAP, implored attendees to aggressively fight barriers to treatment, scrutinize their own work, and learn from their peers.
NCAD West: Focus on Function When Treating Chronic Pain
Las Vegas Recovery Center chief medical officer Mel Pohl, MD, DFASAM, shared risks of using opioids to treat chronic pain and offered non-medication alternatives to improve patients’ ability to function on Thursday at NCAD West.
Back to Top